DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Small EJ, Schellhammer PF, Higano CS. et al.
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.
J Clin Oncol Off J Am Soc Clin Oncol 2006;
24: 3089-3094
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.